Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000710194 | SCV000196858 | benign | not provided | 2018-06-06 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000242900 | SCV000226517 | benign | not specified | 2015-09-22 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000242900 | SCV000307099 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000260800 | SCV000357987 | likely benign | Congenital Muscular Dystrophy, alpha-dystroglycan related | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Illumina Laboratory Services, |
RCV000318279 | SCV000357988 | likely benign | Autosomal recessive limb-girdle muscular dystrophy type 2O | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Athena Diagnostics | RCV000242900 | SCV000614739 | benign | not specified | 2023-04-27 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001084434 | SCV000649955 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2O; Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3 | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000679858 | SCV000807208 | likely benign | Muscle eye brain disease | 2017-12-31 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000710194 | SCV005260362 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV000679858 | SCV001464160 | benign | Muscle eye brain disease | 2019-11-22 | no assertion criteria provided | clinical testing |